Inovio Collaborating With Beijing Advaccine To Advance INO-480...
PLYMOUTH MEETING, Pennsylvania, Jan. 30, 2020 /PRNewswire-AsiaNet/ -- - Agreement will facilitate clinical trial translations in China Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that it is collaborating with Beijing Advaccine Biotechnology Co. to advance the development in China of INO-4800, In...
Authors: LATEST ASIANET NEWS RELEASES